BIOAGE LABS INC (BIOA) Stock Cash Flow
NASDAQ:BIOA - Nasdaq - US09077V1008 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -20.18M | -71.11M | -63.85M | -39.72M | |||
| Depreciation Amortization | 42.00K | 167.00K | 162.00K | 129.00K | |||
| Change In Working Capital | -3.07M | 11.18M | 6.71M | 795.00K | |||
| Interest Paid | 482.00K | 1.42M | 1.16M | 129.00K | |||
| Other non cash items | -8.32M | 8.24M | 19.62M | 2.62M | |||
| OPERATING CASH FLOW | -31.52M | -51.52M | -37.36M | -36.18M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | -626.00K | -366.00K | -166.00K | -103.00K | |||
| Other Investing Activity | N/A | N/A | -100.00K | 0.00 | |||
| INVESTING CASH FLOW | -78.09M | -366.00K | -266.00K | -103.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Debt Issued/Reduced | -19.00M | -6.00M | 11.50M | 2.50M | |||
| Stock Issued/Repurchased | 368.75M | 392.25M | 23.50M | 44.00K | |||
| Other Financing Activity | -4.99M | -5.05M | -63.00K | -45.00K | |||
| FINANCING CASH FLOW | 344.76M | 381.20M | 34.94M | 2.50M | |||
| Exchange Rate Effect | 69.00K | 81.00K | 0.00 | 246.00K | |||
| CHANGE IN CASH | 235.22M | 329.39M | -2.69M | -33.54M | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -31.52M | -51.52M | -37.36M | -36.18M | |||
| Capital Expenditure | -626.00K | -366.00K | -166.00K | -103.00K | |||
| FREE CASH FLOW | -32.15M | -51.89M | -37.53M | -36.28M | |||
All data in USD